QA: Endocyte INC in us_pharma/2011

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001235007_2012_Endocyte_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001235007, Endocyte INC

  xvar xval
0 AssetsCurrent 129,756,024
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 1,107,851
3 remainder_Assets 811,229
4 LiabilitiesCurrent 5,470,002
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 12,833,179
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 10,000,000
9 ResearchAndDevelopmentExpense 28,827,746
10 remainder_Expenses 1,987,873
11 remainder_Revenues 154,557
12 remainder_NetIncome 129,449
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 131,675,104
1 Liabilities 18,303,181
2 Expenses 40,815,619
3 Revenues 154,557
4 StockholdersEquity 113,371,923
5 NetIncome -40,531,613
6 ComprehensiveNetIncome -40,531,613
7 BaseVar 95,538,955
8 EconomicCapitalRatiobeforeLimitedLiability 2.76
9 EconomicCapitalRatio 3.52

Edgar->Model Mapping

Feature Distribution